financetom
Business
financetom
/
Business
/
Texas factory gives Chinese copper firm an edge in tariff war
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Texas factory gives Chinese copper firm an edge in tariff war
Aug 24, 2025 6:27 PM

*

Factory shields its U.S. customers from 50% copper wire

tariffs

*

Production to start later this year, reach 3,000 T by 2028

*

Chinese investments to U.S. have stalled since Trump's

trade war

*

Policymakers ambivalent whether to welcome Chinese

companies

By Amy Lv, Florence Lo and Shubing Wang

GANZHOU, China, Aug 25 (Reuters) - Chinese copper flat

wire manufacturer Wellascent's decision early last year to build

a factory in Texas was a hedge against geopolitical risks. Now

the investment is paying off as U.S. import tariffs boost demand

for its locally produced goods.

The company's plant in Grand Prairie will begin production

later this year and expects to produce 3,000 metric tons of

copper flat wire annually by 2028, serving clients such as

automaker Stellantis ( STLA ), from behind the safety of

Donald Trump's tariff wall.

The factory shields U.S. customers from the 50% tariff

imposed on copper wire imports, along with other semi-finished

copper products like tubes, although refined copper - the base

ingredient - is exempt from tariffs.

"A few prospective clients in the United States were

hesitating about buying our products at the very beginning, as

they were concerned Sino-U.S. trade tensions would make stable

supply uncertain," Hazel Zhu, a board member at Wellascent

Electronic, told Reuters during a tour of their factory in

mid-August.

"A factory in the U.S. means the copper tariffs have in turn

become a golden opportunity for us," she added.

Wellascent plans to invest in three years $100 million in

the U.S. plant, which is expected to generate more than half of

the company's overseas revenue within three years.

Wellascent's investment highlights a rare case where a

Chinese company has benefited despite U.S. tariffs designed to

counter China's perceived industrial dominance. But while the

investment achieves one of Washington's stated aims of bringing

industry to the United States, it underscores ambivalence among

U.S. policymakers about whether to welcome Chinese companies.

Lawmakers proposed removing tax credits from a Ford

electric battery plant because it plans to use technology from

Chinese battery manufacturer CATL, although the

carmaker said last month it believes it will still qualify.

In the solar industry, some domestic producers have voiced

concerns that Chinese rivals setting up factories domestically

benefit from subsidised supply chains in China.

Chinese investments, especially in manufacturing, began

tapering off after Trump's first term and have now stalled,

according to Cameron Johnson, senior partner at consultancy

Tidalwave Solutions. The hostile attitude in Washington is now

echoed in Beijing where regulators are encouraging firms to

avoid the U.S., he added.

"Anybody who is big and could be a target for U.S. or

Chinese governments is doing hardly any investment," Johnson

said. "They (Wellascent) got lucky in many ways."

Net stock of Chinese foreign direct investment in the U.S.

fell by $8.1 billion between 2019 and 2023, U.S. data showed.

Wellascent's Zhu said the company had no regulatory issues

with its Texas investment, winning approval from Chinese and

U.S. authorities.

Still, a temporary 145% tariff on equipment shipments to the

U.S. in April nearly derailed its plans. Zhu said the trade

truce reached in May allowed the firm to avoid a 60% cost

increase and proceed with furnishing the plant.

"The sudden 145% tariff left us completely stunned, as it

left us at a crossroad as for whether to reconsider the

investment; luckily, additional tariffs were removed, allowing

us to smoothly ship a second batch of equipment to the factory,"

Zhu said.

Both sides extended that truce by another 90 days earlier

this month to give negotiators more time to craft a deal that

Trump says is not far off.

If a trade deal is reached, the example set by companies

like Wellascent could become case studies for other Chinese

firms looking to invest in the U.S., Johnson said.

"Their example was pretty unusual, but maybe, if the

relationship gets a bit better, we might see more of it because

there are test cases out there in the market."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Diamondback Energy Insider Sold Shares Worth $1,406,140, According to a Recent SEC Filing
Diamondback Energy Insider Sold Shares Worth $1,406,140, According to a Recent SEC Filing
Nov 10, 2025
04:12 PM EST, 11/10/2025 (MT Newswires) -- Matthew Kaes Van't Hof, Director, Chief Executive Officer, on November 06, 2025, sold 10,000 shares in Diamondback Energy ( FANG ) for $1,406,140. Following the Form 4 filing with the SEC, Van't Hof has control over a total of 119,264 common shares of the company, with 119,264 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1539838/000170466625000006/xslF345X05/wk-form4_1762808506.xml...
Hydrogen fuel cell maker Plug Power misses Q3 revenue estimates
Hydrogen fuel cell maker Plug Power misses Q3 revenue estimates
Nov 10, 2025
Overview * Plug Power ( PLUG ) Q3 revenue was $177 mln, missing analyst expectations * Adjusted EPS for Q3 improved to a loss of $0.12 per share * Company completed $370 mln capital raise, reflecting investor confidence Outlook * Plug Power ( PLUG ) aims for EBITDAS-positive results in the second half of 2026 Result Drivers * ELECTROLYZER GROWTH...
Clinical-stage biotech Celldex's Q3 net loss widens to $67 mln
Clinical-stage biotech Celldex's Q3 net loss widens to $67 mln
Nov 10, 2025
Overview * Celldex Q3 net loss widens to $67 mln, below analysts' expectations * Company reports zero revenue in Q3, down from $3.2 mln in prior year * Positive Phase 2 data for barzolvolimab in multiple indications Outlook * Celldex plans to initiate a global Phase 3 study for ColdU and SD in December 2025 * Celldex expects multiple data...
CoreWeave beats third-quarter revenue estimates on AI computing boom
CoreWeave beats third-quarter revenue estimates on AI computing boom
Nov 10, 2025
Nov 10 (Reuters) - AI cloud provider CoreWeave ( CRWV ) beat Wall Street estimates for third-quarter revenue on Monday, benefiting from surging demand for its computing infrastructure that powers artificial intelligence workloads. The company reported revenue of $1.36 billion for the third quarter, compared with analysts' average estimate of $1.29 billion, according to data compiled by LSEG. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved